- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/76 - Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
Patent holdings for IPC class C07D 233/76
Total number of patents in this class: 78
10-year publication summary
|
2
|
9
|
3
|
9
|
4
|
5
|
3
|
7
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Autifony Therapeutics Limited | 51 |
5 |
| King Faisal University | 934 |
5 |
| Evonik Operations GmbH | 4384 |
5 |
| Buck Institute for Research on Aging | 129 |
4 |
| Oxiscience Wa, LLC | 10 |
4 |
| Bristol-myers Squibb Company | 4757 |
2 |
| The Regents of the University of California | 20815 |
2 |
| Evonik Degussa GmbH | 1351 |
2 |
| Board of Regents of the University of Nebraska | 794 |
2 |
| Elanco US Inc. | 715 |
2 |
| The Glad Products Company | 480 |
2 |
| Monash University | 730 |
2 |
| Swiss Tropical and Public Health Institute | 11 |
2 |
| Bayer AG | 3522 |
1 |
| Huawei Technologies Co., Ltd. | 124115 |
1 |
| DSM IP Assets B.V. | 5389 |
1 |
| Abbvie Inc. | 1799 |
1 |
| Arkema France | 4251 |
1 |
| Auburn University | 497 |
1 |
| The Broad Institute, Inc. | 1986 |
1 |
| Other owners | 32 |